Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 3
2021 6
2022 11
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Antimicrobial defined daily dose in neonatal population.
Villanueva-Bueno C, Montecatine-Alonso E, Jiménez-Parrilla F, Fernández-Llamazares CM, Manrique-Rodríguez S, Zamora-Flores E, Dolz E, Fernández-Polo A, Catillo-Salinas F, Comuñas J, Gallego-Fernández C, González-López M, Gómez-Trevecedo Calvo MT, Gázquez-Pérez R, Álvarez Del Vayo-Benito C, Gil-Navarro MV; Paediatric Antimicrobial Defined Daily Dose Study Group (KiDDDs). Villanueva-Bueno C, et al. Enferm Infecc Microbiol Clin (Engl Ed). 2022 Feb;40(2):59-65. doi: 10.1016/j.eimce.2021.05.012. Enferm Infecc Microbiol Clin (Engl Ed). 2022. PMID: 35120651
Mobile Apps for Hematological Conditions: Review and Content Analysis Using the Mobile App Rating Scale.
Narrillos-Moraza Á, Gómez-Martínez-Sagrera P, Amor-García MÁ, Escudero-Vilaplana V, Collado-Borrell R, Villanueva-Bueno C, Gómez-Centurión I, Herranz-Alonso A, Sanjurjo-Sáez M. Narrillos-Moraza Á, et al. Among authors: villanueva bueno c. JMIR Mhealth Uhealth. 2022 Feb 16;10(2):e32826. doi: 10.2196/32826. JMIR Mhealth Uhealth. 2022. PMID: 35171109 Free PMC article. Review.
Antimicrobial defined daily dose in neonatal population.
Villanueva-Bueno C, Montecatine-Alonso E, Jiménez-Parrilla F, Fernández-Llamazares CM, Manrique-Rodríguez S, Zamora-Flores E, Dolz E, Fernández-Polo A, Catillo-Salinas F, Comuñas J, Gallego-Fernández C, González-López M, Gómez-Trevecedo Calvo MT, Gázquez-Pérez R, Álvarez Del Vayo-Benito C, Gil-Navarro MV; Paediatric Antimicrobial Defined Daily Dose Study Group (KiDDDs). Villanueva-Bueno C, et al. Enferm Infecc Microbiol Clin (Engl Ed). 2021 Jun 25:S0213-005X(21)00191-9. doi: 10.1016/j.eimc.2021.05.007. Online ahead of print. Enferm Infecc Microbiol Clin (Engl Ed). 2021. PMID: 34183175 Free article. English, Spanish.
Antimicrobial Defined Daily Dose in Neonatal Population: Validation in the Clinical Practice.
Villanueva-Bueno C, Montecatine-Alonso E, Jiménez-Parrilla F, González-López M, Manrique-Rodríguez S, Moreno-Ramos F, Cañete-Ramírez C, Dolz E, García-Robles A, Caro-Teller JM, Moral-Pumarega MT, Bergon-Sendin E, Gómez-Trevecedo Calvo MT, Gallego-Fernández C, Vayo-Benito CÁD, Mejías-Trueba M, Gil-Navarro MV, Paediatric Antimicrobial Defined Daily Dose Study Group KiDDDs. Villanueva-Bueno C, et al. Antibiotics (Basel). 2023 Mar 17;12(3):602. doi: 10.3390/antibiotics12030602. Antibiotics (Basel). 2023. PMID: 36978469 Free PMC article.
Acute pancreatitis in a patient treated with imatinib and gefitinib.
Escudero-Vilaplana V, Collado-Borrell R, Villanueva-Bueno C, Álvarez R, Herranz A, Sanjurjo M. Escudero-Vilaplana V, et al. Among authors: villanueva bueno c. J Oncol Pharm Pract. 2021 Jun;27(4):980-983. doi: 10.1177/1078155220949639. Epub 2020 Aug 16. J Oncol Pharm Pract. 2021. PMID: 32799779
Possible heart failure caused by osimertinib in a lung cancer patient.
Ruiz-Briones P, Escudero-Vilaplana V, Collado-Borrell R, Vicente-Valor J, Alvarez R, Villanueva-Bueno C, Narrillos-Moraza Á, Herranz A, Sanjurjo M. Ruiz-Briones P, et al. Among authors: villanueva bueno c. J Oncol Pharm Pract. 2023 Jun;29(4):1015-1020. doi: 10.1177/10781552221143787. Epub 2022 Dec 8. J Oncol Pharm Pract. 2023. PMID: 36480925
Complementary and alternative medicine in cancer patients: characteristics of use and interactions with antineoplastic agents.
Escudero-Vilaplana V, Collado-Borrell R, Gómez Martínez-Sagrera P, Villanueva-Bueno C, Revuelta-Herrero JL, Gonzalez-Haba E, Hoyo-Muñoz Á, Jerez Gilarranz Y, Marzal-Alfaro B, Herranz A, Martin M, Sanjurjo M. Escudero-Vilaplana V, et al. Among authors: villanueva bueno c. J Cancer Res Clin Oncol. 2023 Jul;149(7):2855-2882. doi: 10.1007/s00432-022-04172-1. Epub 2022 Jul 6. J Cancer Res Clin Oncol. 2023. PMID: 35790560
19 results